腫瘍由来エリトポエチンは,がん免疫における免疫抑制スイッチとして作用する
David Kung-Chun Chiu1, Xiangyue Zhang1, Bowie Yik-Ling Cheng2
1Department of Pathology, Stanford University, Stanford, CA, USA.
まとめ
癌細胞からのエリトポエチン (EPO) は,マクロファージのEPORを通じたシグナル伝達により,免疫抑制性腫瘍微環境 (TME) を生み出します. このEPO/EPOR軸を遮断すると,炎症性TMEと腫瘍の回帰が促進され,免疫療法が強化されます.
科学分野:
- 免疫学
- 腫瘍学
- 癌 研究
背景:
- 効果的ながん免疫療法には 腫瘍に対する強力な免疫反応が必要です
- 多くの癌は 免疫の検出と破壊を回避するメカニズムを 開発します
- 癌治療の成果を向上させるには 免疫逃避を理解することが重要です
研究 の 目的:
- 腫瘍が免疫監視を回避する 分子機構を調査する
- 腫瘍の微環境 (TME) 免疫型を決定する重要な要因を特定する.
- 肝細胞癌 (HCC) の免疫回避を標的とした治療戦略を探求する.
主な方法:
- 肝細胞がん (HCC) の自発的なマウスモデルを使用した.
- 炎症性 (T細胞に富んだ) と非炎症性 (T細胞欠乏した) 腫瘍の微小環境を比較した.
- 腫瘍関連マクロファージ (TAM) に対するエリトポエチン (EPO) とその受容体 (EPOR) の作用を調査した.
主要な成果:
- 腫瘍から分泌されるEPOは,腫瘍の免疫型を決定する重要な要因として特定された.
- TAMにEPO信号を送ると 免疫抑制性非炎症性TMEが誘発される.
- EPO/EPORシグナルによるNRF2媒介のヘム欠乏により,TAMは免疫調節される.
- 腫瘍由来のEPOまたはTAM EPORの抑制は,炎症性TMEと腫瘍の回帰につながった.
結論:
- EPO/EPOR軸は免疫抑制スイッチとして作用し,抗腫瘍免疫を阻害する.
- EPO/EPOR経路をターゲットにすることで,炎症のないTMEを炎症したものに変換し,腫瘍の収縮を促進します.
- この経路は,がん免疫療法の有効性を高めるための潜在的な治療目標です.
関連する概念動画
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K


